About Us - Accelevir

Clinical Trial Services

Accelevir provides integrated end-to-end molecular, cellular and immunological functional capabilities to support Biopharma and Investigator initiated clinical trials and drug development.

Learn More

Industry Solutions

Specialized analytics and assay solutions.

Learn More

Therapeutic Modalities

End-point measurements utilizing immune function assay, molecular platforms to generate and inform programs within Gene Editing, Cell Therapy, Vaccine and Infectious Disease.

Learn More

Translational Science

A Johns Hopkins University, key thought leaders, and customers within the HIV-1 cure community. Our commitment to customers is defined by being responsive with expanding assay capabilities and portfolio.

Our journey is defined by a strong scientific focus, operational discipline and commitment to meeting customer needs. Our collaborators and customers within the HIV-1 cure community continue to drive and support our expanding assay capabilities beyond infectious disease.

How We Can Help

Provide critical measurements within a CLIA environment.

Combine cutting-edge molecular technologies that include digital PCR, single target culture techniques, high fidelity sequencing, and data-driven analytics.